Education
About Us
Working with TipRanks
Follow Us
Robert K Zeldin Insider Profile
4 Followers
Robert K Zeldin, EVP & Chief Medical Officer at Acceleron Pharma, holds 19.10K shares in Acceleron Pharma (Ticker: XLRN), holds ― shares in Immunovant (Ticker: IMVT), holds 168.34K shares in Meiragtx Holdings (Ticker: MGTX).
Robert K Zeldin Acceleron Pharma (XLRN)EVP & Chief Medical Officer
Acceleron Pharma (XLRN)
EVP & Chief Medical Officer
Not Ranked
Robert K Zeldin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert K Zeldin holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert K Zeldin
Robert K Zeldin's Trading History
Acceleron Pharma
Jan 29, 2019
―
Uninformative Buy
―
$3.41M
Immunovant
―
Chief Medical Officer
―
―
Meiragtx Holdings
Jan 21, 2026
CMO
Uninformative Buy
156.18K
$1.21M
List of latest transactions for each holding click on a transaction to see Robert K Zeldin's performance on stock
You May Also Like
Robert K Zeldin insider profile FAQ
What is the percentage of profitable transactions made by Robert K Zeldin?
The percentage of profitable transactions made by Robert K Zeldin is ―.
What is the average return per transaction made by Robert K Zeldin?
The average return per transaction made by Robert K Zeldin is ―.
What stocks does Robert K Zeldin hold?
Robert K Zeldin holds: XLRN, IMVT, MGTX stocks.
What was Robert K Zeldin’s latest transaction?
Robert K Zeldin latest transaction was an Uninformative Buy of ―.
What was Robert K Zeldin's most profitable transaction?
Robert K Zeldin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert K Zeldin's role in Acceleron Pharma?
Robert K Zeldin's role in Acceleron Pharma is EVP & Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.